PORT ST LUCIE, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)VACCINE AND GENE THERAPY INSTITUTE OF FLORIDA CORP, founded in 2008, is a micro nonprofit in the Medical Research sector that reported $19 in total revenue in fiscal year 2017. Revenue fell 99% from the prior year — a significant decline worth monitoring. Expenses of $386K exceeded revenue, resulting in a 2031905% operating deficit.
THE MISSION OF THE VACCINE AND GENE THERAPY INSTITUTE OF FLORIDA (VGTI-FL) IS TO "TRANSLATE RESEARCH INTO HEALTH" BY PROVIDING A BETTER UNDERSTANDING OF THE HUMAN IMMUNE RESPONSE TO PATHOGENS AND CANCERS AND THE PROCESS OF AGING.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2017 | 2016 | Change | |
|---|---|---|---|
| Revenue | $19 | $1,712 | -1.0% |
| Expenses | $386,081 | $1,964,588 | -0.8% |
| Net Income | $-386,062 | $-1,962,876 | -0.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MICHAEL GOLDBERG | RECEIVER | 50.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2018 | $19 | $386,081 | $217,466 | $-386,062 |
Compare VACCINE AND GENE THERAPY INSTITUTE OF FLORIDA CORP with other nonprofits in Florida and across the country.